Literature DB >> 21380811

Differential cross-tolerance development between single and repeated immobilization stress on the antinociceptive effect induced by β-endorphin, 5-hydroxytryptamine, morphine, and WIN55,212-2 in the inflammatory mouse pain mode.

Young-Jun Seo1, Min-Soo Kwon, Seung-Min Choi, Jin-Koo Lee, Soo-Hyun Park, Jun-Sub Jung, Yun-Beom Sim, Hong-Won Suh.   

Abstract

We have evaluated the possible underlying mechanisms of immobilization stress-induced analgesia (SIA) by behavioral cross-tolerance studies and molecular studies. In the behavioral studies, the cross-tolerance between single or repeated immobilization SIA and the antinociceptive effects of β-endorphin, morphine, 5-hydroxytryptamine (5-HT), or WIN55,212-2 were assessed. Both single and repeated (×7) immobilization stress significantly attenuated the β-endorphin and 5-hydroxytryptamine-induced antinociception in the 2nd phase of formalin response, respectively. However, these cross-tolerances disappeared in prolonged repetition of the stress (×14). Neither single nor repeated (×7 and ×14) immobilization stress affected the antinociceptive effect of morphine or WIN55,212-2 at all. We also found that immobilization stress activated hypothalamic proopiomelanocortin (POMC) gene and β-endorphin expression. Since, it has potent inhibitory activity on the noxious stimuli-induced POMC expression, immobilization stress seemed to dissipate the POMC gene expression process. Meanwhile, we did not find any changes in the opioid receptors' (mu-, delta- and kappa-receptor) and the cannabinoid receptors' (CB1 and CB2) expressions in the midbrain regions elicited by single or repeated stress. These results suggested that a single immobilization stress activates the descending pain modulatory system, which is mainly mediated through endorphinergic and serotonergic activation. Moreover, the tolerance of SIA induced by repeated stresses may be due to the prolonged activation of these systems induced by repeated immobilization.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21380811     DOI: 10.1007/s12272-011-0213-1

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  4 in total

1.  Significance of neuronal cytochrome P450 activity in opioid-mediated stress-induced analgesia.

Authors:  Lindsay B Hough; Julia W Nalwalk; Weizhu Yang; Xinxin Ding
Journal:  Brain Res       Date:  2014-07-11       Impact factor: 3.252

2.  Antidepressant-like effects of BU10119, a novel buprenorphine analogue with mixed κ/μ receptor antagonist properties, in mice.

Authors:  Abdulrahman Almatroudi; Mehrnoosh Ostovar; Christopher P Bailey; Stephen M Husbands; Sarah J Bailey
Journal:  Br J Pharmacol       Date:  2017-11-06       Impact factor: 8.739

3.  Diabetic neuropathy is associated with increased pain perception, low serum beta-endorphin and increase insulin resistance among Nigerian cohorts in Ekiti State.

Authors:  Olabode O Akintoye; Bamidele V Owoyele; Oyesanmi A Fabunmi; Taiwo H Raimi; Adesola A Oniyide; Abimbola O Akintoye; Ayodeji J Ajibare; David D Ajayi; Gbenga S Adeleye
Journal:  Heliyon       Date:  2020-07-11

4.  The Molecular Signatures of Acute-immobilization-induced Antinociception and Chronic-immobilization-induced Antinociceptive Tolerance.

Authors:  Jing-Hui Feng; Hee-Jung Lee; Hong-Won Suh
Journal:  Exp Neurobiol       Date:  2019-12-31       Impact factor: 3.261

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.